Pharma & Biotech

Evotec SE has announced a sweeping operational overhaul, sending its stock price lower as the market digested a sharply reduced...

The biopharmaceutical company aTyr Pharma is entering a pivotal period for its lead therapeutic candidate, efzofitimod. Two major clinical and...

As spring approaches, Axsome Therapeutics finds itself at a critical juncture. The biopharmaceutical firm is strengthening its commercial footing with...

The German biotech firm BioNTech is navigating its most significant transition since the peak of the pandemic. Co-founders Ugur Sahin...

In a strategic move to bolster its core pharmaceutical business, Novartis has received expanded U.S. regulatory approval for its immunology...

Canadian biotech firm Onco-Innovations has bolstered its financial position through a private placement, raising capital earmarked for its transition into...

Bayer's ambitious corporate overhaul is facing intensified pressure from external uncertainties. As CEO Bill Anderson drives internal cost-cutting initiatives, the...

The launch of Evotec's "Horizon" restructuring plan was intended to signal a new beginning. Financial markets, however, have delivered a...

Sensei Biotherapeutics is navigating a significant corporate transformation. The biotechnology firm has recently completed a comprehensive restructuring and integrated new...

After a period of significant price swings, Illumina's shares are showing signs of entering a more stable phase. A growing...